메뉴 건너뛰기




Volumn 48, Issue 1, 2004, Pages 27-31

Guidelines for the hormone treatment of women in the menopausal transition and beyond: Position Statement by the Executive Committee of the International Menopause Society

(1)  Wright, Jean a  

a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

EID: 3042588958     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.03.001     Document Type: Article
Times cited : (18)

References (16)
  • 1
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
    • Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 288:2002;321-333
    • (2002) J. Am. Med. Assoc. , vol.288 , pp. 321-333
    • Rossouw, J.E.1    Anderson, G.L.2    Prentice, R.L.3
  • 2
    • 0042093742 scopus 로고    scopus 로고
    • Estrogen plus progestin and the risk of coronary heart disease
    • Manson J.E., Hsia J., Johnson K.C., et al. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 349:2003;523-534
    • (2003) N. Engl. J. Med. , vol.349 , pp. 523-534
    • Manson, J.E.1    Hsia, J.2    Johnson, K.C.3
  • 3
    • 0037830132 scopus 로고    scopus 로고
    • Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative Randomized Trial
    • Chlebowski R.T., Hendrix S.L., Langer R.D., et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative Randomized Trial. J. Am. Med. Assoc. 289:2003;3243-3253
    • (2003) J. Am. Med. Assoc. , vol.289 , pp. 3243-3253
    • Chlebowski, R.T.1    Hendrix, S.L.2    Langer, R.D.3
  • 4
    • 0042018741 scopus 로고    scopus 로고
    • Breast cancer and hormone replacement therapy in the Million Women Study
    • Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362:419-27.
    • (2003) Lancet , vol.362 , pp. 419-427
  • 5
    • 0032547326 scopus 로고    scopus 로고
    • Randomized trial of estrogen plus progestin for secondary prevention of coronary disease in postmenopausal women
    • Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary disease in postmenopausal women. J. Am. Med. Assoc. 280:1998;605-613
    • (1998) J. Am. Med. Assoc. , vol.280 , pp. 605-613
    • Hulley, S.1    Grady, D.2    Bush, T.3
  • 6
    • 0034710627 scopus 로고    scopus 로고
    • Effects of estrogen replacement on the progression of coronary artery atherosclerosis
    • Herrington D.M., Reboussin D.R., Brosnihan K.B., et al. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N. Engl. J. Med. 343:2000;522-529
    • (2000) N. Engl. J. Med. , vol.343 , pp. 522-529
    • Herrington, D.M.1    Reboussin, D.R.2    Brosnihan, K.B.3
  • 7
    • 0012868624 scopus 로고    scopus 로고
    • Effects of estrogen plus progestin on health-related quality of life
    • Hays J., Ockene J.K., Brunner R.L., et al. Effects of estrogen plus progestin on health-related quality of life. N. Engl. J. Med. 348:2003;1839-1854
    • (2003) N. Engl. J. Med. , vol.348 , pp. 1839-1854
    • Hays, J.1    Ockene, J.K.2    Brunner, R.L.3
  • 8
    • 1642332489 scopus 로고    scopus 로고
    • Early initiation of hormone therapy and clinical cardioprotection: The Women's Health Initiative (WHI) could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition
    • in press.
    • Naftolin F, Taylor HS, Karas R. Early initiation of hormone therapy and clinical cardioprotection: the Women's Health Initiative (WHI) could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril, 2004, in press.
    • (2004) Fertil Steril
    • Naftolin, F.1    Taylor, H.S.2    Karas, R.3
  • 9
    • 3042687002 scopus 로고    scopus 로고
    • Effects of hormone replacement therapy on the risks of breast cancer and cardiovascular disease: The validity of the epidemiological evidence
    • Schneider HPG, Naftolin F, editors. Climacteric medicine - Where do we go? London: Parthenon Publishing; in press.
    • Shapiro S, Effects of hormone replacement therapy on the risks of breast cancer and cardiovascular disease: the validity of the epidemiological evidence. In: Schneider HPG, Naftolin F, editors. Climacteric medicine - Where do we go? Proceedings of the 4th Workshop of the International Menopause Society. London: Parthenon Publishing; 2004, in press.
    • (2004) Proceedings of the 4th Workshop of the International Menopause Society
    • Shapiro, S.1
  • 10
    • 0347509279 scopus 로고    scopus 로고
    • Considerations in interpreting the cardiovascular effects of hormone replacement therapy observed in the WHI: Timing is everything
    • Karas R.H., Clarkson T.B. Considerations in interpreting the cardiovascular effects of hormone replacement therapy observed in the WHI: timing is everything. Menopausal Med. 10:2003;8-12
    • (2003) Menopausal Med. , vol.10 , pp. 8-12
    • Karas, R.H.1    Clarkson, T.B.2
  • 11
    • 0034687825 scopus 로고    scopus 로고
    • A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease
    • Grodstein F., Manson J.E., Colditz G.A., Willett W.C., Speizer F.E., Stampfer M.J. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann. Intern. Med. 133:2000;933-941
    • (2000) Ann. Intern. Med. , vol.133 , pp. 933-941
    • Grodstein, F.1    Manson, J.E.2    Colditz, G.A.3    Willett, W.C.4    Speizer, F.E.5    Stampfer, M.J.6
  • 12
    • 0030610461 scopus 로고    scopus 로고
    • Postmenopausal hormone treatment and mortality
    • Grodstein F., Stampfer M.J., Colditz G.A., et al. Postmenopausal hormone treatment and mortality. N. Engl. J. Med. 336:1997;1769-1775
    • (1997) N. Engl. J. Med. , vol.336 , pp. 1769-1775
    • Grodstein, F.1    Stampfer, M.J.2    Colditz, G.A.3
  • 13
    • 0034063090 scopus 로고    scopus 로고
    • Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis
    • Joakimsen O., Bønaa K.H., Stensland-Bugge E., Jacobsen B.K. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis. J. Clin. Epidemiol. 53:2000;525-530
    • (2000) J. Clin. Epidemiol. , vol.53 , pp. 525-530
    • Joakimsen, O.1    Bønaa, K.H.2    Stensland-Bugge, E.3    Jacobsen, B.K.4
  • 14
    • 0034710639 scopus 로고    scopus 로고
    • Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women
    • Hu F.B., Stampfer M.J., Manson J.E., et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N. Engl. J. Med. 343:2000;530-537
    • (2000) N. Engl. J. Med. , vol.343 , pp. 530-537
    • Hu, F.B.1    Stampfer, M.J.2    Manson, J.E.3
  • 15
    • 0038742057 scopus 로고    scopus 로고
    • Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: Results from the estrogen in the prevention of atherosclerosis trial
    • Mack W.J., Hameed A.B., Xiang M., et al. Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial. Atherosclerosis. 168:2003;91-98
    • (2003) Atherosclerosis , vol.168 , pp. 91-98
    • MacK, W.J.1    Hameed, A.B.2    Xiang, M.3
  • 16
    • 0025223339 scopus 로고
    • Inhibition of coronary atherosclerosis by 17β-estradiol in ovariectomized monkeys: Lack of an effect of added progesterone
    • Adams M.R., Kaplan J.R., Manuck S.B., et al. Inhibition of coronary atherosclerosis by 17β-estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis. 10:1990;1051-1057
    • (1990) Arteriosclerosis , vol.10 , pp. 1051-1057
    • Adams, M.R.1    Kaplan, J.R.2    Manuck, S.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.